(Q44767634)

English

Nordic 5-fluorouracil/leucovorin bolus schedule combined with oxaliplatin (Nordic FLOX) as first-line treatment of metastatic colorectal cancer

scientific article published in January 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Nordic 5-fluorouracil/leucovorin bolus schedule combined with oxaliplatin (Nordic FLOX) as first-line treatment of metastatic colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Olav Dahl

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Halfdan Sørbye

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

827-831

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A systematic overview of chemotherapy effects in colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Dose-effect relationship of bolus 5-fluorouracil in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860310018972

21 January 2018

Identifiers

10.1080/02841860310018972

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44767634&oldid=2212045999"